U.S.FDA Steps Up Scrutiny To Small Suppliers
  • Prabha Hedge
  • Mar 12 2014

March 12: It is not only Indian drug makers but also suppliers who are facing increasing scrutiny by the U.S. FDA. Bloomberg TV India has learnt that the regulator has been issuing letters to smaller ingredient suppliers as well to keep a check on manufacturing practices and equipments. Priya Sheth shares a detailed report on the same.